Prithvi Exchange (India) Regulatory Approval

Other Announcement

Prithvi Exchange (India) Other Announcement

Prithvi Exchange (India) Ltd submitted its quarterly shareholding pattern for the period ending 30-Sep-2026. This is a standard regulatory filing detailing the company's equity structure.

New Order Win

Prithvi Exchange (India) Bags New Order from India Tourism Development Corporation Limited

Prithvi Exchange received a Letter of Acceptance from India Tourism Development Corporation for foreign currency collection services. The contract covers a two-year period.

From

India Tourism Development Corporation Limited (ITDC)

Execution

2 years

Product Launch

Prithvi Exchange (India) Product Launch

Prithvi Exchange (India) Limited launched its mobile application for customers and a new 'Partner Hub' portal for its business partners to enhance digital service delivery.

Annual General Meeting

Prithvi Exchange (India) Annual General Meeting

Prithvi Exchange (India) Limited held its 31st AGM on August 27, 2026. Shareholders approved a 5% final dividend and the adoption of audited financial statements.

Earnings Call

Prithvi Exchange (India) Investor Presentation: Key Takeaways

Prithvi Exchange reported Q1 FY27 revenue of ₹1,108.2 Cr, up 25.11% YoY, despite a 37.5% decline in PAT to ₹0.71 Cr.

Financial Results

Prithvi Exchange (India) Q1 FY27 Results: Net Profit ₹0.7 Cr, Down 36.4% YoY

Prithvi Exchange (India) Ltd reported revenue from operations of ₹1,108 Cr (+29.4% YoY) and net profit of ₹0.7 Cr (-36.4% YoY) for Q1 FY27.

Key figure

Net profit ₹0.7 Cr · -36.4% YoY

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.